MedPath
NMPA Approval

Recombinant Human Follitropin Prefilled Syringe

国药准字SJ20160039

August 27, 2021

S20160039

Drug Information

重组人促卵泡激素注射液

果纳芬

注射剂

22μg (300IU)

生物制品

August 27, 2021

August 26, 2026

Company Information

Applicant Company

Merck Europe BV

Gustav Mahlerplein 102, 1082 MA Amsterdam, The Netherlands

Manufacturing Company

merck serono s.p.a.

Via Delle Magnolie 15, (loc. frazione Zona Industriale), 70026 Modugno (BA), Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

重组人促卵泡激素注射液 - NMPA 批准文号 | MedPath